Source
PANXEON Blood Test Detects Early Pancreatic Cancer SECONDARY_TEXT retrieval pending
Retrieval by Galedra
Not yet fetched. Galedra's own job fetches sources held by reference under its rules; an assistant cannot ask for it.
Claims from this source
No claims have been extracted from this source yet.
Locations
| Locator | Excerpt |
|---|---|
QUOTE {} | In the testing cohort, PANXEON had a false-positive rate of: 3.2% among low-risk controls; 15.6% among high-risk controls. |
QUOTE {} | For stage I–II pancreatic cancer, the combined approach reached a sensitivity of: 86.8%. |
QUOTE {} | The study evaluated how accurately the biomarker distinguished people with and without pancreatic cancer. It did not test whether using PANXEON to screen the general population reduces deaths from pancreatic cancer. |